AbstractAn excessive tissue response to prosthetic arterial graft material leads to intimal hyperplasia (IH), the leading cause of late graft failure. Seroma and abnormal capsule formation may also occur after prosthetic material implantation. The matricellular protein Thrombospondin-2 (TSP-2) has shown to be upregulated in response to biomaterial implantation. This study evaluates the uptake and release of small interfering RNA (siRNA) from unmodified and surface functionalized electrospun PET graft materials. ePET graft materials were synthesized using electrospinning technology. Subsets of the ePET materials were then chemically modified to create surface functional groups. Unmodified and surface-modified ePET grafts were dip-coated in s...
ObjectiveWe tested the hypothesis that rapamycin coated onto, and eluted from, expanded polytetraflu...
ObjectiveStent grafts are increasingly recognized as useful devices for endovascular repair of aorti...
Clinical applications of RNA interference-based therapeutics such as small interfering RNAs (siRNAs)...
Background—Despite decades of research, anastomotic intimal hyperplasia remains a major cause of del...
AbstractPurpose: Downstream anastomotic intimal hyperplasia in prosthetic arterial grafts remains a ...
Background: RNA interference (RNAi) is a powerful platform utilized to target transcription of speci...
AbstractPurpose: Anastomotic intimal hyperplasia remains a significant cause of delayed prosthetic a...
AbstractObjective: Anastomotic intimal hyperplasia remains a leading mechanism of prosthetic arteria...
Restenosis is the formation of blockages occurring at the site of angioplasty or stent placement. In...
ObjectivesThe goal of this study was to evaluate the ability of recombinant human thrombomodulin (rT...
ObjectiveThe objective of this study was to examine the effect of tissue plasminogen activator (tPA)...
Remodeling of the extracellular matrix resulting from increased secretion of metalloproteinase enzym...
Presently, a new era of drug-eluting stents is continuing to improve late adverse effects such as th...
BackgroundEndothelial gene silencing via small interfering RNA (siRNA) transfection represents a pro...
AbstractPurpose: Seeding prosthetic arterial grafts with genetically modified endothelial cells (ECs...
ObjectiveWe tested the hypothesis that rapamycin coated onto, and eluted from, expanded polytetraflu...
ObjectiveStent grafts are increasingly recognized as useful devices for endovascular repair of aorti...
Clinical applications of RNA interference-based therapeutics such as small interfering RNAs (siRNAs)...
Background—Despite decades of research, anastomotic intimal hyperplasia remains a major cause of del...
AbstractPurpose: Downstream anastomotic intimal hyperplasia in prosthetic arterial grafts remains a ...
Background: RNA interference (RNAi) is a powerful platform utilized to target transcription of speci...
AbstractPurpose: Anastomotic intimal hyperplasia remains a significant cause of delayed prosthetic a...
AbstractObjective: Anastomotic intimal hyperplasia remains a leading mechanism of prosthetic arteria...
Restenosis is the formation of blockages occurring at the site of angioplasty or stent placement. In...
ObjectivesThe goal of this study was to evaluate the ability of recombinant human thrombomodulin (rT...
ObjectiveThe objective of this study was to examine the effect of tissue plasminogen activator (tPA)...
Remodeling of the extracellular matrix resulting from increased secretion of metalloproteinase enzym...
Presently, a new era of drug-eluting stents is continuing to improve late adverse effects such as th...
BackgroundEndothelial gene silencing via small interfering RNA (siRNA) transfection represents a pro...
AbstractPurpose: Seeding prosthetic arterial grafts with genetically modified endothelial cells (ECs...
ObjectiveWe tested the hypothesis that rapamycin coated onto, and eluted from, expanded polytetraflu...
ObjectiveStent grafts are increasingly recognized as useful devices for endovascular repair of aorti...
Clinical applications of RNA interference-based therapeutics such as small interfering RNAs (siRNAs)...